Medigoxin
From Wikipedia, the free encyclopedia
Medigoxin
|
|
Systematic (IUPAC) name | |
4-[(3S,5R,8R,9S,10S,12R,13S,14S)-12,14- Dihydroxy-3- [(2R,4S,5S,6R)-4-hydroxy- 5-[(2S,4S,5S,6R)-4-hydroxy- 5-[(2S,4S,5S,6R)-4-hydroxy- 5-methoxy-6-methyl-oxan-2-yl]oxy- 6-methyl-oxan-2-yl]oxy-6-methyl- oxan-2-yl]oxy-10,13-dimethyl- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthren- 17-yl]-5H-furan-2-one |
|
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C42H66O14 |
Mol. mass | 794.965 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Medigoxin is a cardiac glycoside closely related to digoxin.
Biochemicals | Major Families of||
Peptides | Amino acids | Nucleic acids | Carbohydrates | Lipids | Terpenes | Carotenoids | Tetrapyrroles | Enzyme cofactors | Steroids | Flavonoids | Alkaloids | Polyketides | Glycosides | ||
Analogues of nucleic acids: | Types of Glycosides | Analogues of nucleic acids: |
Bond: | O-glycosidic bond | S-glycosidic bond | N-glycosidic bond | |
---|---|---|
Geometry: | α-Glycoside | β-Glycoside | 1,4-Glycoside | 1,6-Glycoside | |
Glycone: | Glucoside | Fructoside | Glucuronide | |
Aglycone: | Alcoholic glycoside | Anthraquinone glycoside | Coumarin glycoside | Cyanogenic glycoside | Flavonoid glycoside | Phenolic glycoside | Saponin | Cardiac glycoside | Steviol glycoside | Thioglycoside | Glycosylamine | Bufanolide | Cardenolide |